If you or a loved one received a Bard PowerPort implant and suffered complications like infections, fractures, or migration, you may be entitled to significant compensation. Lawsuits against C.R. Bard and Becton Dickinson allege these defective port catheters caused severe injuries, especially in cancer patients. Learn about the PowerPort, health risks (clarifying no direct cancer link), the latest news, and how direct2attorney can help you seek justice.
What Is the Bard PowerPort?
The Bard PowerPort is an implantable port catheter device designed to deliver medications, fluids, or chemotherapy directly into a patient’s bloodstream. Inserted under the skin, typically in the chest, it connects to a vein for easy access during treatments, commonly for cancer patients. Introduced by C.R. Bard (now part of Becton Dickinson), the PowerPort uses a polyurethane tube mixed with barium sulfate for X-ray visibility. However, lawsuits claim design flaws, including weak materials prone to cracking, fracturing, or migrating, lead to dangerous complications like infections, blood clots, and organ damage.
At Direct2Attorney, we believe in your right to justice.
Our legal specialists will review your case thoroughly to identify your options.
We will assess your eligibility and assist you in filing your case, ensuring you feel supported throughout the process.
There is no established link between the Bard PowerPort and cancer causation; rather, the device is often used in cancer patients for chemotherapy delivery. Lawsuits focus on other serious health risks caused by defective PowerPorts, such as catheter fractures, migration, and infections. A 2023 lawsuit highlighted how degraded barium sulfate creates cracks where bacteria can grow, causing life-threatening infections, especially in immunocompromised patients. Fractures can lead to pieces migrating to the heart or lungs, requiring emergency surgery, as seen in a case where a Kansas woman’s PowerPort broke during chemotherapy. These complications add significant physical and emotional burdens to already vulnerable patients.
If you’ve experienced complications due to the Bard PowerPort device, we are here to help you secure the compensation you deserve. Contact Us
Bard PowerPort Lawsuit Updates
As of April 2025, the Bard PowerPort multidistrict litigation (MDL 3081) in Arizona includes hundreds of cases, with new filings added monthly. A key deadline looms: by April 28, 2025, both sides must submit six lawsuits each for bellwether trials, set to begin in 2026, to guide potential settlements. Recent cases include a Kansas woman who suffered a hematoma and fever from a fractured PowerPort and an Iowa plaintiff requiring emergency surgery after catheter fragments reached her heart., Settlement talks are ongoing, with potential payouts estimated at $50,000–$500,000 for severe cases. Direct2attorney is actively accepting cases, urging victims to act before state statutes of limitations expire.
Lawsuits claim C.R. Bard’s PowerPort catheters are defective, causing fractures, migrations, infections, and other injuries due to poor design and manufacturing.
Patients implanted with a Bard PowerPort who suffered complications like infections, fractures, or migration, or their families, may qualify with proof of injury.
Risks include infections, blood clots, catheter fractures, migration to organs, and organ damage, but there is no direct link to causing cancer.
Compensation may cover medical expenses, pain and suffering, lost wages, and punitive damages, with payouts potentially ranging from $50,000 to $500,000.
Statutes of limitations vary by state, typically one to three years from injury or discovery. Consult an attorney to confirm your deadline.
The Arizona MDL is growing, with bellwether trials planned for 2026. New cases are being filed, and settlements are under discussion.
Contact direct2attorney’s mass tort experts for a free consultation to evaluate your claim and guide you through the legal process.
